Melax Technologies
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Melax Technologies Inc. (Melax Tech) was a Houston-based artificial intelligence and natural language processing company founded in 2017 out of the Texas Medical Center Innovation Factory, led by CEO Andre Pontin. It used AI and NLP to extract information from biomedical text data for the healthcare and life sciences industries - cohort discovery, clinical-trials optimization and knowledge integration - and was trusted by more than 650 organizations. It raised $600,000 in grant funding from the National Institutes of Health. In May 2023 it was acquired by Intelligent Medical Objects (IMO), the Chicago-area clinical-terminology company, in IMO's first-ever acquisition; terms were not disclosed.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Founded
Melax Technologies was founded in 2017 at the Texas Medical Center Innovation Factory in Houston, applying AI and NLP to biomedical text.
- Grants
The company raised $600,000 in grant funding from the National Institute of Health and the National Institute of Allergy and Infectious Diseases.
- Acquired
Intelligent Medical Objects (IMO) acquired Melax Tech in May 2023 - IMO's first acquisition; terms were not disclosed.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.